Ensysce Biosciences, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ensysce Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Ensysce Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $645K.
  • Ensysce Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$6.31M, a 54.2% increase year-over-year.
  • Ensysce Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$10.7M, a 55.8% increase from 2022.
  • Ensysce Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$24.2M, a 21.9% decline from 2021.
  • Ensysce Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$19.9M, a 1132% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$10.7M +$13.5M +55.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 -$24.2M -$4.35M -21.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 -$19.9M -$18.3M -1132% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$1.61M +$1.72M +51.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$3.33M -$2.37M -247% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-06-08
2018 -$959K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.